Synaptogenix, Inc.
General ticker "SNPX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.9M (TTM average)
Synaptogenix, Inc. follows the US Stock Market performance with the rate: 7.8%.
Estimated limits based on current volatility of 17.2%: low 3.92$, high 5.19$
Factors to consider:
- Price in estimated range
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.78$, 11.10$]
- 2024-12-30 to 2025-12-30 estimated range: [1.78$, 7.00$]
Financial Metrics affecting the SNPX estimates:
- Negative: Non-GAAP EPS, $ of -41.37 <= 0.05
- Negative: Operating cash flow per share per price, % of -79.34 <= 1.99
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -25.05 <= 2.94
- Negative: Operating profit margin, % of -100 <= 0.04
- Negative: Industry earnings per price (median), % of -30.12 <= 0
- Negative: Industry operating profit margin (median), % of -98.99 <= 0.07
Short-term SNPX quotes
Long-term SNPX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $12.62MM | $26.36MM | $8.31MM |
| Operating Income | $-12.62MM | $-26.36MM | $-8.31MM |
| Non-Operating Income | $0.01MM | $20.79MM | $2.28MM |
| R&D Expense | $4.34MM | $6.32MM | $1.97MM |
| Income(Loss) | $-12.61MM | $-5.57MM | $-6.04MM |
| Profit(Loss)* | $-12.60MM | $-5.46MM | $-6.04MM |
| Stockholders Equity | $33.53MM | $32.69MM | $24.35MM |
| Assets | $35.52MM | $38.61MM | $31.11MM |
| Operating Cash Flow | $-8.71MM | $-11.21MM | $-5.17MM |
| Capital expenditure | $0.00MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $-0.01MM | $-2.00MM |
| Financing Cash Flow | $37.13MM | $14.48MM | $-1.64MM |
| Earnings Per Share** | $-63.02 | $-19.99 | $-29.60 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.